Currently, used anticancer drugs are found to be poorly water soluble and highly potent in nature. They act non-selectively on both tumour as well as normal cells. This non-selectivity is being tried to overcome by means of selective or targeted tumor drug delivery with improvised safety and efficacy. This book discusses nanocarrier systems for drug delivery.